122 Participants Needed

Transcranial Stimulation for Alcoholism

JE
JM
Overseen ByJoAnna Mathena
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this observational and interventional study is to better understand the involvement of the cerebellum in the brain reward system in persons with alcohol use disorder (AUD). The main questions it aims to answer are: 1. What is the nature of cerebellar input to the ventral tegmental area (VTA) in the brain reward system, and how is it perturbed in AUD? 2. What is the relationship between measures of cerebellar integrity and magnitude of reward activation to alcohol-related cues in cerebellar, VTA and other brain reward structures? 3. What is the therapeutic potential of cerebellar transcranial direct current stimulation (tDCS) for modulating alcohol cue reactivity, associated alcohol craving, and cerebellar - VTA functional connectivity in the brain reward system? Persons with AUD will be compared with healthy control participants.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are using anticonvulsant medication, you must not have used it in the past 3 months to participate.

What data supports the effectiveness of the treatment Cerebellar Transcranial Direct Current Stimulation for alcoholism?

Research on transcranial direct current stimulation (tDCS) shows it can reduce alcohol cravings and improve quality of life in alcohol-dependent individuals. Studies have also found that tDCS targeting the dorsolateral prefrontal cortex (a brain area involved in decision-making) can decrease relapse rates and improve decision-making in addiction disorders.12345

Is transcranial direct current stimulation (tDCS) of the cerebellum safe for humans?

Research shows that cerebellar tDCS is generally safe for humans, with no serious adverse effects reported in studies involving over 33,200 sessions and 1,000 subjects, including vulnerable populations. It has been well-tolerated in both adults and children, with no reports of irreversible injury.678910

How does transcranial stimulation differ from other treatments for alcoholism?

Transcranial direct current stimulation (tDCS) is a unique treatment for alcoholism because it involves non-invasive electrical stimulation of the brain, specifically targeting the prefrontal cortex, which can reduce the risk of alcohol relapse and improve quality of life. Unlike traditional treatments that may involve medication or therapy, tDCS uses electrical currents to modulate brain activity, offering a novel approach to managing alcohol dependence.29111213

Research Team

JE

John E Desmond, PhD

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for individuals with Alcohol Use Disorder who have completed at least 8 years of education. It's not suitable for left-handed people, non-native English speakers, those with serious medical conditions or liver issues, metal implants incompatible with MRI scans, pregnant women, low IQ (<90), current drug use (except nicotine/caffeine), or central nervous system disorders.

Inclusion Criteria

Completed at least 8 years of education

Exclusion Criteria

Non-native English speaker
I have not had any brain disorders, seizures, or taken seizure medications recently.
Left handed
See 11 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational and Interventional Study

Participants undergo fMRI and tDCS to study cerebellar involvement in AUD

4-6 weeks
Multiple visits for fMRI and tDCS sessions

Follow-up

Participants are monitored for changes in brain activation and connectivity post-intervention

4 weeks

Treatment Details

Interventions

  • Cerebellar Transcranial Direct Current Stimulation
Trial OverviewThe study investigates the cerebellum's role in the brain reward system affected by AUD. It examines how cerebellar input to the VTA is altered in AUD and explores if cerebellar transcranial direct current stimulation can reduce alcohol craving and affect brain connectivity.
Participant Groups
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Cathodal cerebellar transcranial direct current stimulation (ctDCS)Experimental Treatment1 Intervention
For ctDCS, the cathodal (-) electrode will be positioned over the right cerebellum 1 cm below and 3 cm lateral to the inion, and the anodal (+) electrode will be placed on the contralateral supraorbital area (FP2 EEG location).
Group II: Anodal cerebellar transcranial direct current stimulation (atDCS)Experimental Treatment1 Intervention
For atDCS, anode/cathode locations are reversed from those of ctDCS..
Group III: Sham cerebellar transcranial direct current stimulation (stDCS)Placebo Group1 Intervention
For stDCS, the electrodes will be configured randomly as atDCS 50% of the time, and as ctDCS 50% of the time.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials
865
Recruited
1,091,000+

Findings from Research

A randomized, double-blind, placebo-controlled trial will evaluate the efficacy of transcranial direct current stimulation (tDCS) in reducing alcohol consumption among 340 participants with alcohol use disorders across 14 centers in France and Monaco.
The study aims to assess not only the reduction in alcohol intake but also improvements in craving, mood, quality of life, and cognitive function, highlighting the potential of tDCS as a novel treatment for addiction.
Efficacy of transcranial direct current stimulation (tDCS) in reducing consumption in patients with alcohol use disorders: study protocol for a randomized controlled trial.Trojak, B., Soudry-Faure, A., Abello, N., et al.[2018]
In a phase II clinical trial with 33 severe alcoholics, those receiving active transcranial direct current stimulation (tDCS) had a significantly lower relapse rate (50% abstinent) compared to the sham group (11.8% abstinent) after six months, indicating its potential efficacy in reducing relapse risk.
Participants in the tDCS group reported improved quality of life, particularly in the environment domain, suggesting that tDCS not only helps with abstinence but may also enhance overall well-being.
A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence.Klauss, J., Penido Pinheiro, LC., Silva Merlo, BL., et al.[2016]
Transcranial direct current stimulation (tDCS) applied to the dorsolateral prefrontal cortex (DLPFC) significantly reduced alcohol craving in 13 patients with alcohol dependence when exposed to alcohol cues, compared to sham stimulation (p<0.0001).
The study suggests that tDCS not only decreases craving but also prevents further increases in craving from alcohol cues, indicating its potential as a rapid and effective treatment strategy for managing alcohol dependence.
Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study.Boggio, PS., Sultani, N., Fecteau, S., et al.[2022]

References

Efficacy of transcranial direct current stimulation (tDCS) in reducing consumption in patients with alcohol use disorders: study protocol for a randomized controlled trial. [2018]
A randomized controlled trial of targeted prefrontal cortex modulation with tDCS in patients with alcohol dependence. [2016]
Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study. [2022]
The Effect of Different Transcranial Direct Current Stimulation (tDCS) Protocols on Drug Craving and Cognitive Functions in Methamphetamine Addicts. [2022]
Multi-session electrical neuromodulation effects on craving, relapse and cognitive functions in cocaine use disorder: A randomized, sham-controlled tDCS study. [2021]
The clinical application of transcranial direct current stimulation in patients with cerebellar ataxia: a systematic review. [2022]
Cerebellar Transcranial Direct Current Stimulation in Children with Autism Spectrum Disorder: A Pilot Study on Efficacy, Feasibility, Safety, and Unexpected Outcomes in Tic Disorder and Epilepsy. [2022]
Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016. [2022]
Cerebellar tDCS: how to do it. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Targeting the Human Cerebellum with Transcranial Direct Current Stimulation to Modulate Behavior: a Meta-Analysis. [2022]
tDCS of the Cerebellum: Where Do We Stand in 2016? Technical Issues and Critical Review of the Literature. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
Differential Behavioral and Neural Effects of Regional Cerebellar tDCS. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
Cerebellar patients do not benefit from cerebellar or M1 transcranial direct current stimulation during force-field reaching adaptation. [2018]